APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Vaccines

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.

Selected research

Market Outlook & Growth Opportunities

Global Swine Vaccines Market Outlook and Growth Opportunities 2026

26 December 2025207 pages

Choose your research edition.

Industry ResearchSwine Vaccines Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Vaccines Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Swine Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Vaccines Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Vaccines Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.

Read the full market overview

China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.

This report provides an overview of the global Swine Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Swine Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Swine Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Swine Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Swine Vaccines Segment by Company

Merck

Boehringer Ingelheim

Jinyu Bio-Technology

CAHIC

Tecon

Zoetis

Ceva

Hile Bio

Chopper Biology

WINSUN

Hipra

Ringpu Biology

ChengDu Tecbond

DHN

CAVAC

Virbac

HVRI

Bioveta

Swine Vaccines Segment by Type

CSF Vaccines

FMD Vaccines

Porcine Circovirus Vaccines

PRRS Vaccines

Others

Swine Vaccines Segment by Application

Government Tender

Market Sales

Swine Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Swine Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Swine Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Swine Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Swine Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Swine Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Swine Vaccines industry.

Chapter 3: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Swine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Swine Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Swine Vaccines Industry Trends Table 2. Swine Vaccines Industry Drivers Table 3. Swine Vaccines Industry Opportunities and Challenges Table 4. Swine Vaccines Industry Restraints Table 5. Global Swine Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Swine Vaccines Revenue Share by Company (2021-2026) Table 7. Global Swine Vaccines Sales Volume by Company (M Doses) & (2021-2026) Table 8. Global Swine Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Swine Vaccines Average Price (USD/K Doses) of Company (2021-2026) Table 10. Global Swine Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Swine Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Swine Vaccines Company, Product Type & Application Table 13. Global Swine Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Swine Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of CSF Vaccines Table 18. Significant Companies of FMD Vaccines Table 19. Significant Companies of Porcine Circovirus Vaccines Table 20. Significant Companies of PRRS Vaccines Table 21. Significant Companies of Others Table 22. Global Swine Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (M Doses) Table 23. Global Swine Vaccines Sales Volume by Type (2021-2026) & (M Doses) Table 24. Global Swine Vaccines Sales Volume by Type (2027-2032) & (M Doses) Table 25. Global Swine Vaccines Sales Volume Share by Type (2021-2026) Table 26. Global Swine Vaccines Sales Volume Share by Type (2027-2032) Table 27. Global Swine Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Swine Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Swine Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Swine Vaccines Sales Value Share by Type (2021-2026) Table 31. Global Swine Vaccines Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Government Tender Table 33. Significant Companies of Market Sales Table 34. Global Swine Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (M Doses) Table 35. Global Swine Vaccines Sales Volume by Application (2021-2026) & (M Doses) Table 36. Global Swine Vaccines Sales Volume by Application (2027-2032) & (M Doses) Table 37. Global Swine Vaccines Sales Volume Share by Application (2021-2026) Table 38. Global Swine Vaccines Sales Volume Share by Application (2027-2032) Table 39. Global Swine Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Swine Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Swine Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Swine Vaccines Sales Value Share by Application (2021-2026) Table 43. Global Swine Vaccines Sales Value Share by Application (2027-2032) Table 44. Global Swine Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 45. Global Swine Vaccines Sales by Region (2021-2026) & (M Doses) Table 46. Global Swine Vaccines Sales Market Share by Region (2021-2026) Table 47. Global Swine Vaccines Sales by Region (2027-2032) & (M Doses) Table 48. Global Swine Vaccines Sales Market Share by Region (2027-2032) Table 49. Global Swine Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Swine Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Swine Vaccines Sales Value Share by Region (2021-2026) Table 52. Global Swine Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Swine Vaccines Sales Value Share by Region (2027-2032) Table 54. Global Swine Vaccines Market Average Price (USD/K Doses) by Region (2021-2026) Table 55. Global Swine Vaccines Market Average Price (USD/K Doses) by Region (2027-2032) Table 56. Global Swine Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Table 57. Global Swine Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 59. Global Swine Vaccines Sales Market Share by Country (2021-2026) Table 60. Global Swine Vaccines Sales by Country (2027-2032) & (M Doses) Table 61. Global Swine Vaccines Sales Market Share by Country (2027-2032) Table 62. Global Swine Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Swine Vaccines Sales Value Market Share by Country (2021-2026) Table 64. Global Swine Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Swine Vaccines Sales Value Market Share by Country (2027-2032) Table 66. Merck Company Information Table 67. Merck Business Overview Table 68. Merck Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 69. Merck Swine Vaccines Product Portfolio Table 70. Merck Recent Development Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim Swine Vaccines Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. Jinyu Bio-Technology Company Information Table 77. Jinyu Bio-Technology Business Overview Table 78. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 79. Jinyu Bio-Technology Swine Vaccines Product Portfolio Table 80. Jinyu Bio-Technology Recent Development Table 81. CAHIC Company Information Table 82. CAHIC Business Overview Table 83. CAHIC Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 84. CAHIC Swine Vaccines Product Portfolio Table 85. CAHIC Recent Development Table 86. Tecon Company Information Table 87. Tecon Business Overview Table 88. Tecon Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 89. Tecon Swine Vaccines Product Portfolio Table 90. Tecon Recent Development Table 91. Zoetis Company Information Table 92. Zoetis Business Overview Table 93. Zoetis Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 94. Zoetis Swine Vaccines Product Portfolio Table 95. Zoetis Recent Development Table 96. Ceva Company Information Table 97. Ceva Business Overview Table 98. Ceva Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 99. Ceva Swine Vaccines Product Portfolio Table 100. Ceva Recent Development Table 101. Hile Bio Company Information Table 102. Hile Bio Business Overview Table 103. Hile Bio Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 104. Hile Bio Swine Vaccines Product Portfolio Table 105. Hile Bio Recent Development Table 106. Chopper Biology Company Information Table 107. Chopper Biology Business Overview Table 108. Chopper Biology Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 109. Chopper Biology Swine Vaccines Product Portfolio Table 110. Chopper Biology Recent Development Table 111. WINSUN Company Information Table 112. WINSUN Business Overview Table 113. WINSUN Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 114. WINSUN Swine Vaccines Product Portfolio Table 115. WINSUN Recent Development Table 116. Hipra Company Information Table 117. Hipra Business Overview Table 118. Hipra Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 119. Hipra Swine Vaccines Product Portfolio Table 120. Hipra Recent Development Table 121. Ringpu Biology Company Information Table 122. Ringpu Biology Business Overview Table 123. Ringpu Biology Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 124. Ringpu Biology Swine Vaccines Product Portfolio Table 125. Ringpu Biology Recent Development Table 126. ChengDu Tecbond Company Information Table 127. ChengDu Tecbond Business Overview Table 128. ChengDu Tecbond Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 129. ChengDu Tecbond Swine Vaccines Product Portfolio Table 130. ChengDu Tecbond Recent Development Table 131. DHN Company Information Table 132. DHN Business Overview Table 133. DHN Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 134. DHN Swine Vaccines Product Portfolio Table 135. DHN Recent Development Table 136. CAVAC Company Information Table 137. CAVAC Business Overview Table 138. CAVAC Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 139. CAVAC Swine Vaccines Product Portfolio Table 140. CAVAC Recent Development Table 141. Virbac Company Information Table 142. Virbac Business Overview Table 143. Virbac Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 144. Virbac Swine Vaccines Product Portfolio Table 145. Virbac Recent Development Table 146. HVRI Company Information Table 147. HVRI Business Overview Table 148. HVRI Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 149. HVRI Swine Vaccines Product Portfolio Table 150. HVRI Recent Development Table 151. Bioveta Company Information Table 152. Bioveta Business Overview Table 153. Bioveta Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 154. Bioveta Swine Vaccines Product Portfolio Table 155. Bioveta Recent Development Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Swine Vaccines Distributors List Table 159. Swine Vaccines Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Swine Vaccines Product Image Figure 2. Global Swine Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Swine Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global Swine Vaccines Sales Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Swine Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. CSF Vaccines Image Figure 10. FMD Vaccines Image Figure 11. Porcine Circovirus Vaccines Image Figure 12. PRRS Vaccines Image Figure 13. Others Image Figure 14. Global Swine Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 15. Global Swine Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Swine Vaccines Sales Volume Share by Type (2021-2032) Figure 17. Global Swine Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Swine Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Swine Vaccines Sales Value Share by Type (2021-2032) Figure 20. Government Tender Image Figure 21. Market Sales Image Figure 22. Global Swine Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 23. Global Swine Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Swine Vaccines Sales Volume Share by Application (2021-2032) Figure 25. Global Swine Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Swine Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Swine Vaccines Sales Value Share by Application (2021-2032) Figure 28. Global Swine Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 29. Global Swine Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Swine Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Swine Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Swine Vaccines Sales Value (2021-2032) & (US$ Million) Figure 33. North America Swine Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Swine Vaccines Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Swine Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Swine Vaccines Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Swine Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Swine Vaccines Sales Value (2021-2032) & (US$ Million) Figure 39. South America Swine Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Swine Vaccines Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Swine Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Swine Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Swine Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Swine Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Swine Vaccines Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Swine Vaccines Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • CSF Vaccines
  • FMD Vaccines
  • Porcine Circovirus Vaccines
  • PRRS Vaccines
  • Others
Applications
  • Government Tender
  • Market Sales
Companies covered
  • Merck
  • Boehringer Ingelheim
  • Jinyu Bio-Technology
  • CAHIC
  • Tecon
  • Zoetis
  • Ceva
  • Hile Bio
  • Chopper Biology
  • WINSUN
  • Hipra
  • Ringpu Biology
  • ChengDu Tecbond
  • DHN
  • CAVAC
  • Virbac
  • HVRI
  • Bioveta

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Swine Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Swine Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Swine Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Swine Vaccines Market Dynamics
  1. 2.1 Swine Vaccines Industry Trends
  2. 2.2 Swine Vaccines Industry Drivers
  3. 2.3 Swine Vaccines Industry Opportunities and Challenges
  4. 2.4 Swine Vaccines Industry Restraints
3 Swine Vaccines Market by Company
  1. 3.1 Global Swine Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Swine Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Swine Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Swine Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Swine Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Swine Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Swine Vaccines Company Product Type and Application
  8. 3.8 Global Swine Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Swine Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Swine Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Swine Vaccines Market by Type
  1. 4.1 Swine Vaccines Type Introduction
  2. 4.1.1 CSF Vaccines
  3. 4.1.2 FMD Vaccines
  4. 4.1.3 Porcine Circovirus Vaccines
  5. 4.1.4 PRRS Vaccines
  6. 4.1.5 Others
  7. 4.2 Global Swine Vaccines Sales Volume by Type
  8. 4.2.1 Global Swine Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Swine Vaccines Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Swine Vaccines Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Swine Vaccines Sales Value by Type
  12. 4.3.1 Global Swine Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Swine Vaccines Sales Value by Type (2021-2032)
  14. 4.3.3 Global Swine Vaccines Sales Value Share by Type (2021-2032)
5 Swine Vaccines Market by Application
  1. 5.1 Swine Vaccines Application Introduction
  2. 5.1.1 Government Tender
  3. 5.1.2 Market Sales
  4. 5.2 Global Swine Vaccines Sales Volume by Application
  5. 5.2.1 Global Swine Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Swine Vaccines Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Swine Vaccines Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Swine Vaccines Sales Value by Application
  9. 5.3.1 Global Swine Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Swine Vaccines Sales Value by Application (2021-2032)
  11. 5.3.3 Global Swine Vaccines Sales Value Share by Application (2021-2032)
6 Swine Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Swine Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Swine Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Swine Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Swine Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Swine Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Swine Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Swine Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Swine Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Swine Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Swine Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Swine Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Swine Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Swine Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Swine Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Swine Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Swine Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Swine Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Swine Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Swine Vaccines Sales Value Share by Country, 2025 VS 2032
7 Swine Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Swine Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Swine Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Swine Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Swine Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Swine Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Swine Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Swine Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Swine Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Swine Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Swine Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Swine Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Swine Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Swine Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Swine Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Swine Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Swine Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Swine Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Swine Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Swine Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Swine Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Swine Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Swine Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Swine Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Swine Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Swine Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Swine Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Swine Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Swine Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Swine Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Swine Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Swine Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Swine Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Swine Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Swine Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Swine Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Swine Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Swine Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Swine Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Swine Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Swine Vaccines Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Jinyu Bio-Technology
  14. 8.3.1 Jinyu Bio-Technology Company Information
  15. 8.3.2 Jinyu Bio-Technology Business Overview
  16. 8.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
  18. 8.3.5 Jinyu Bio-Technology Recent Developments
  19. 8.4 CAHIC
  20. 8.4.1 CAHIC Company Information
  21. 8.4.2 CAHIC Business Overview
  22. 8.4.3 CAHIC Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CAHIC Swine Vaccines Product Portfolio
  24. 8.4.5 CAHIC Recent Developments
  25. 8.5 Tecon
  26. 8.5.1 Tecon Company Information
  27. 8.5.2 Tecon Business Overview
  28. 8.5.3 Tecon Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Tecon Swine Vaccines Product Portfolio
  30. 8.5.5 Tecon Recent Developments
  31. 8.6 Zoetis
  32. 8.6.1 Zoetis Company Information
  33. 8.6.2 Zoetis Business Overview
  34. 8.6.3 Zoetis Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Zoetis Swine Vaccines Product Portfolio
  36. 8.6.5 Zoetis Recent Developments
  37. 8.7 Ceva
  38. 8.7.1 Ceva Company Information
  39. 8.7.2 Ceva Business Overview
  40. 8.7.3 Ceva Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Ceva Swine Vaccines Product Portfolio
  42. 8.7.5 Ceva Recent Developments
  43. 8.8 Hile Bio
  44. 8.8.1 Hile Bio Company Information
  45. 8.8.2 Hile Bio Business Overview
  46. 8.8.3 Hile Bio Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hile Bio Swine Vaccines Product Portfolio
  48. 8.8.5 Hile Bio Recent Developments
  49. 8.9 Chopper Biology
  50. 8.9.1 Chopper Biology Company Information
  51. 8.9.2 Chopper Biology Business Overview
  52. 8.9.3 Chopper Biology Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Chopper Biology Swine Vaccines Product Portfolio
  54. 8.9.5 Chopper Biology Recent Developments
  55. 8.10 WINSUN
  56. 8.10.1 WINSUN Company Information
  57. 8.10.2 WINSUN Business Overview
  58. 8.10.3 WINSUN Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 WINSUN Swine Vaccines Product Portfolio
  60. 8.10.5 WINSUN Recent Developments
  61. 8.11 Hipra
  62. 8.11.1 Hipra Company Information
  63. 8.11.2 Hipra Business Overview
  64. 8.11.3 Hipra Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hipra Swine Vaccines Product Portfolio
  66. 8.11.5 Hipra Recent Developments
  67. 8.12 Ringpu Biology
  68. 8.12.1 Ringpu Biology Company Information
  69. 8.12.2 Ringpu Biology Business Overview
  70. 8.12.3 Ringpu Biology Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ringpu Biology Swine Vaccines Product Portfolio
  72. 8.12.5 Ringpu Biology Recent Developments
  73. 8.13 ChengDu Tecbond
  74. 8.13.1 ChengDu Tecbond Company Information
  75. 8.13.2 ChengDu Tecbond Business Overview
  76. 8.13.3 ChengDu Tecbond Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
  78. 8.13.5 ChengDu Tecbond Recent Developments
  79. 8.14 DHN
  80. 8.14.1 DHN Company Information
  81. 8.14.2 DHN Business Overview
  82. 8.14.3 DHN Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 DHN Swine Vaccines Product Portfolio
  84. 8.14.5 DHN Recent Developments
  85. 8.15 CAVAC
  86. 8.15.1 CAVAC Company Information
  87. 8.15.2 CAVAC Business Overview
  88. 8.15.3 CAVAC Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 CAVAC Swine Vaccines Product Portfolio
  90. 8.15.5 CAVAC Recent Developments
  91. 8.16 Virbac
  92. 8.16.1 Virbac Company Information
  93. 8.16.2 Virbac Business Overview
  94. 8.16.3 Virbac Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Virbac Swine Vaccines Product Portfolio
  96. 8.16.5 Virbac Recent Developments
  97. 8.17 HVRI
  98. 8.17.1 HVRI Company Information
  99. 8.17.2 HVRI Business Overview
  100. 8.17.3 HVRI Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 HVRI Swine Vaccines Product Portfolio
  102. 8.17.5 HVRI Recent Developments
  103. 8.18 Bioveta
  104. 8.18.1 Bioveta Company Information
  105. 8.18.2 Bioveta Business Overview
  106. 8.18.3 Bioveta Swine Vaccines Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Bioveta Swine Vaccines Product Portfolio
  108. 8.18.5 Bioveta Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Swine Vaccines Value Chain Analysis
  2. 9.1.1 Swine Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Swine Vaccines Sales Mode & Process
  6. 9.2 Swine Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Swine Vaccines Distributors
  9. 9.2.3 Swine Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst